Ubs Group Ag Spectrum Pharmaceuticals Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.65 - $1.31 $209 - $421
322 Added 9.46%
3,725 $3,000
Q1 2023

May 12, 2023
SELL
$0.38 - $1.07 $113 - $318
-298 Reduced 8.05%
3,403 $2,000
Q4 2022

Feb 08, 2023
BUY
$0.32 - $0.52 $482 - $784
1,508 Added 68.76%
3,701 $1,000
Q3 2022

Nov 10, 2022
BUY
$0.43 - $1.56 $15 - $56
36 Added 1.67%
2,193 $1,000
Q4 2021

Feb 14, 2022
SELL
$1.27 - $2.42 $1.2 Million - $2.28 Million
-942,812 Reduced 99.77%
2,157 $3,000
Q3 2021

Nov 15, 2021
BUY
$2.15 - $3.82 $1.79 Million - $3.19 Million
834,596 Added 756.16%
944,969 $2.06 Million
Q2 2021

Aug 13, 2021
SELL
$2.89 - $4.45 $583,424 - $898,352
-201,877 Reduced 64.65%
110,373 $414,000
Q1 2021

May 12, 2021
BUY
$2.9 - $4.09 $889,444 - $1.25 Million
306,705 Added 5531.2%
312,250 $1.02 Million
Q4 2020

Feb 11, 2021
BUY
$3.38 - $5.14 $3,745 - $5,695
1,108 Added 24.97%
5,545 $19,000
Q3 2020

Nov 12, 2020
SELL
$2.99 - $4.9 $1,563 - $2,562
-523 Reduced 10.54%
4,437 $18,000
Q2 2020

Jul 31, 2020
SELL
$2.11 - $3.38 $73,381 - $117,549
-34,778 Reduced 87.52%
4,960 $17,000
Q1 2020

May 01, 2020
BUY
$1.83 - $3.45 $10,237 - $19,299
5,594 Added 16.38%
39,738 $93,000
Q4 2019

Feb 14, 2020
SELL
$3.5 - $10.35 $513,586 - $1.52 Million
-146,739 Reduced 81.12%
34,144 $124,000
Q3 2019

Nov 14, 2019
BUY
$7.03 - $9.7 $1.24 Million - $1.71 Million
175,789 Added 3450.9%
180,883 $1.5 Million
Q2 2019

Aug 14, 2019
SELL
$7.36 - $11.26 $3,635 - $5,562
-494 Reduced 8.84%
5,094 $44,000
Q1 2019

May 14, 2019
SELL
$9.08 - $11.84 $1.83 Million - $2.38 Million
-201,168 Reduced 97.3%
5,588 $60,000
Q4 2018

Feb 14, 2019
SELL
$6.39 - $16.99 $629,811 - $1.67 Million
-98,562 Reduced 32.28%
206,756 $1.81 Million
Q3 2018

Nov 14, 2018
BUY
$16.52 - $24.82 $5.01 Million - $7.53 Million
303,230 Added 14522.51%
305,318 $5.13 Million
Q2 2018

Aug 14, 2018
SELL
$14.31 - $21.75 $3.7 Million - $5.62 Million
-258,220 Reduced 99.2%
2,088 $44,000
Q1 2018

May 15, 2018
BUY
$16.09 - $23.07 $3.16 Million - $4.53 Million
196,447 Added 307.62%
260,308 $4.19 Million
Q4 2017

Feb 14, 2018
SELL
$13.36 - $20.73 $1.02 Million - $1.58 Million
-76,157 Reduced 54.39%
63,861 $1.21 Million
Q3 2017

Nov 14, 2017
BUY
$8.75 - $14.07 $412,772 - $663,738
47,174 Added 50.81%
140,018 $1.97 Million
Q2 2017

Aug 14, 2017
BUY
N/A
38,626 Added 71.24%
92,844 $691,000
Q1 2017

Nov 14, 2017
BUY
N/A
54,218
54,218 $353,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0
View Full List

About SPECTRUM PHARMACEUTICALS INC

SPPI Quotes by TradingView
  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email